1. IgG abnormalities in HIV-positive Malawian women initiating antiretroviral therapy during pregnancy persist after 24 months of treatment.
- Author
-
Baroncelli, Silvia, Maria Galluzzo, Clementina, Liotta, Giuseppe, Orlando, Stefano, Ciccacci, Fausto, Andreotti, Mauro, Mpwhere, Robert, Luhanga, Richard, Sagno, Jean Baptiste, Amici, Roberta, Marazzi, Maria Cristina, and Giuliano, Marina
- Subjects
- *
HIV-positive women , *ANTIRETROVIRAL agents , *THIRD trimester of pregnancy , *PREGNANT women , *PREGNANCY - Abstract
• Hypergammaglobulinemia is common in Malawian HIV-positive pregnant women. • Twenty-four months of antiretroviral therapy improved but did not normalize IgG anomalies. • The IgG2 isotype remained highly underrepresented. • The potential influence of immunoglobulin disorders should be considered when assessing the risk of infection in HIV-exposed infants. Hypergammaglobulinemia and anomalies in the IgG subclass distribution are common in HIV-infected individuals and persist even after many years of antiretroviral therapy (ART). The aim of this study was to investigate the IgG profile and dynamics in pregnant HIV-infected Malawian women in the Option B era. Thirty-seven treatment-naive women received ART from the third trimester of pregnancy to 6 months post delivery (end of the breastfeeding period). ART continuation (group C) or interruption (group I) was then decided on the basis of the CD4+ cell count at enrolment (>350 or ≤350/μl). Total IgG and IgG subclasses were determined in maternal serum using a nephelometric assay at baseline and at 6 and 24 months postpartum. At enrolment, 36/37 women had IgG levels >15 g/l and there was a predominance of the IgG1 isotype (more than 90%) in parallel with underrepresentation of IgG2 (5.0%). After 6 months of ART, both groups showed a significant median decrease in total IgG (−3.1 g/l in group I, −3.5 g/l in group C) and in IgG1 (−4.0 g/l and −3.6 g/l, respectively), but only a modest recovery in IgG2 levels (+0.16 in group I, +0.14 g/l in group C). At month 24, hypergammaglobulinemia was still present in 73.7% of women in group C, although a significant reduction was observed in total IgG level and in IgG1 and IgG3 subclasses (p < 0.0001 in all cases). IgG2 levels did not show any significant change. In group I at 24 months, total IgG and IgG subclasses had returned to levels comparable to those at baseline. The beneficial effects of 24 months of ART appear to be limited in the B-cell compartment, with an incomplete reduction of total IgG levels and no recovery of IgG2 depletion. A short ART period did not have significant effects on IgG abnormalities in women who interrupted treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF